STAT
SEPTEMBER 13, 2024
Elevance Health’s Anthem Blue Cross Blue Shield requested money from health-care providers and alleged they falsified patient medical records in ways that led the insurer to cover the medications. Enjoy, and see you soon… A major U.S. The amount demanded in a few cases totaled more than $1 million.
Pharmaceutical Technology
JULY 20, 2022
However, the American Medical Association (AMA) released a statement warning that while most patients benefit from Paxlovid, it is not for everyone. The US FDA has not announced any updates to Lagevrio’s label.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
JUNE 28, 2024
In fact, the drug often sees shortages due to high demand for off-label prescriptions for weight loss. Although some healthcare providers prescribe Ozempic off-label for weight loss, insurance often won’t cover Ozempic for these uses unless it’s medically justified and no alternative treatments exist.
Hospital Pharmacy Europe
FEBRUARY 8, 2024
Benefits are evident both in dispensing (for example, to count pills, label prescription vials, store drugs and integrate bar coding through automated dispensing cabinets, automated inventory management systems and pharmacy carousels) and in preparation (by automated workflow systems and compounding robotics for intravenous drugs).
InCrowd
JULY 17, 2024
Traditionally reliant on established methodologies, HEOR is now rapidly incorporating RWD and Real-World Evidence (RWE) to support label expansions and integrate with conventional research activities. AI’s ability to analyze complex datasets can revolutionize HEOR by providing deeper, more nuanced insights.
Hospital Pharmacy Europe
FEBRUARY 22, 2024
If these results can be integrated into a patient’s medical records, they can be used to inform the prescription of future medicines throughout that patient’s life. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: An open-label, multicentre, controlled, cluster-randomised crossover implementation study.
The FDA Law Blog
OCTOBER 2, 2023
the approvals of Relyvrio and Skyclarys), the combination of open-label extension data and natural history data proved to be an invaluable source of confirmatory evidence to support approval. objective clinical outcomes in the context of detailed medical record collection). In these recent experiences (i.e.,
Expert insights. Personalized for you.
110 
Let's personalize your content